Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Markers in GHD Children Treated With Saizen
NCT01187550Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Mar 2007
- Primary completion
- Sep 2008
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of somatropin in growth hormone deficiency (GHD), sponsored by Merck KGaA. Started Mar 2007; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01187550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187550.